AGN News and Press, Allergan plc From 06/13/19

THOUSAND OAKS, Calif. , June 13, 2019 /PRNewswire/ -- Amgen (NASDAQ:AMGN) and Allergan plc (NYSE:AGN) today announced that the U.S. Food and Drug Administration (FDA) has approved KANJINTI ™ (trastuzumab-anns) for all approved indications of the reference product, Herceptin ®...

James Brumley says in Kiplinger Investing : "Rich people often get perpetually richer for a reason, so it could be worthwhile to study what billionaires and high-asset hedge funds are plowing their long-term capital into." As any collection of stocks is more clearly understood when subj...

Quick Take Akero Therapeutics ( AKRO ) has filed to raise gross proceeds of $75.0 million from a U.S. IPO, according to an S-1/A registration statement . The firm is developing a treatment for metabolic diseases with high unmet clinical needs, with an initial focus on non-alcoholic steato...

This article is part of a series that provides an ongoing analysis of the changes made to Wallace Weitz’s 13F portfolio on a quarterly basis. It is based on Weitz’s regulatory 13F Form filed on 05/14/2019. Please visit our Tracking Wallace Weitz’s Weitz Investment Manag...

Agilent (NYSE: A ) initiated with Overweight rating and $83 (18% upside) price target at Piper Jaffray. More news on: Agilent Technologies, Inc., Danaher Corporation, Teleflex Incorporated, Healthcare stocks news, Stocks on the move, , Read more ...

The FDA's Anesthetic and Analgesic Drug Products Advisory Committee and the Drug Safety and Risk Management Advisory Committee will jointly mee t tomorrow and Wednesday, June 11 & 12, to seek public input on the clinical utility and safety concerns associated with higher range opioid an...

This article is part of a series that provides an ongoing analysis of the changes made to Southeastern Asset Management's 13F portfolio on a quarterly basis. It is based on Southeastern's regulatory 13F Form filed on 05/15/2019. Please visit our Tracking Mason Hawkins' Southeastern Asset Ma...

Allergan plc (AGN) Jefferies 2019 Healthcare Conference Call June 06, 2019 02:00 PM ET Company Participants Manisha Narasimhan - Vice President of Investor Relations and Strategic Initiatives William Meury - Executive Vice President and Chief Commercial Officer Conference Call...

This article is part of a series that provides an ongoing analysis of the changes made to Larry Robbins’ 13F portfolio on a quarterly basis. It is based on Robbins’ regulatory 13F Form filed on 05/15/2019. Please visit our Tracking Larry Robbins’ Glenview Capital Mana...

Evolus ( EOLS +15.9% ) is up on 70% higher volume in reaction to the rapid enrollment in its Jeuveau Experience Treatment program. More than 3,000 provider accounts signed up in three weeks and 67% of patients switched from market leader BOTOX from Allergan ( AGN -1.9% ). Enrollment in...